Guidance for industry. Diabetes Mellitus – Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes - US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER)
Letzter Zugriff am 29.04.2015